Regulatory inspections of interactive response technology systems have surged 140% since 2022, signaling intensified global scrutiny of data integrity, randomization, and system validation in clinical trials.
Justine Koor
Advertisement
Justine Koor, Director, Quality Assurance at IQVIA
Articles by Justine Koor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
4
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
